TLX — Telix Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapMomentum Trap
- AU$1.17bn
- AU$1.15bn
- AU$7.60m
Annual cashflow statement for Telix Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | |||||
| Capital Expenditures | |||||
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | |||||
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | |||||
| Financing Cash Flow Items | |||||
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | |||||
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash |